Drägerwerk AG Reports Steady Growth in Order Intake
LÜBECK - Drägerwerk AG & Co. KGaA is making noteworthy strides in the first nine months of 2024, posting a 1.4 percent increase in order intake compared to last year, totaling about EUR 2,421 million. This impressive growth can largely be credited to the company's safety division, which has achieved a remarkable 6.5 percent rise in order intake.
Sales Performance Overview
While there has been a decline in demand for ventilators, especially from international markets, Dräger's net sales have remained resilient, dipping only slightly by 0.4 percent to approximately EUR 2,295 million. The positive trend in the safety division, with a 5.5 percent increase in net sales, counterbalances the 4.6 percent decrease seen in the medical division, largely due to what some might call base effects from the previous year.
Improvement in Profit Margins
The company's gross margin has seen a slight improvement, rising to 44.4 percent from 44.0 percent in the prior year. Earnings before interest and taxes (EBIT) also recorded a modest increase, growing by roughly four percent to reach EUR 80 million, with several one-time effects contributing close to EUR 30 million to this outcome.
Quarterly Highlights
In the third quarter of 2024, Dräger witnessed an order intake growth of 2.6 percent, amounting to around EUR 816 million. The safety division delivered particularly strong results, achieving an 11.9 percent increase in order intake. Conversely, the medical division experienced a decline of 3.4 percent primarily due to challenges in the Chinese market. The Group's gross margin for this quarter was noted at 43.5 percent, while EBIT was recorded at EUR 24 million, which included a significant one-time effect from a real estate transaction.
Annual Projections and Expectations
Looking ahead, Dräger has reiterated its annual projections, predicting a net sales increase of between 1.0 to 5.0 percent and expecting an EBIT margin in the range of 2.5 to 5.5 percent. The company envisions achieving net sales growth towards the lower end of this forecast, while aiming for an EBIT margin closer to the upper end.
Upcoming Financial Results
Dräger is set to release its comprehensive financial results for the first nine months on October 29, 2024. This report provides insights based on a company's statement, showcasing their performance in a challenging market environment.
Frequently Asked Questions
What are Dräger's key growth figures for 2024?
Drägerwerk AG experienced a 1.4 percent rise in order intake, with safety division growth at 6.5 percent.
How have Dräger's sales figures changed this year?
Net sales showed a slight decline of 0.4 percent, standing at approximately EUR 2,295 million.
What insights were provided about the safety and medical divisions?
The safety division grew by 5.5 percent while the medical division saw a decrease of 4.6 percent.
What is the status of Dräger's profit margins?
Dräger's gross margin slightly improved to 44.4 percent, with EBIT rising to EUR 80 million this year.
When will Dräger release its financial results for 2024?
The detailed financial results for the first nine months will be released on October 29, 2024.
